Pathway Financial Advisors LLC Has $619,000 Position in The Procter & Gamble Company (NYSE:PG)

Pathway Financial Advisors LLC lowered its holdings in The Procter & Gamble Company (NYSE:PGFree Report) by 7.5% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 3,575 shares of the company’s stock after selling 291 shares during the quarter. Pathway Financial Advisors LLC’s holdings in Procter & Gamble were worth $619,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Itau Unibanco Holding S.A. purchased a new position in Procter & Gamble during the 2nd quarter worth $28,000. Fairway Wealth LLC purchased a new position in Procter & Gamble during the 2nd quarter worth $29,000. Transcendent Capital Group LLC purchased a new position in Procter & Gamble during the 4th quarter worth $31,000. Ruedi Wealth Management Inc. boosted its holdings in Procter & Gamble by 64.7% during the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock worth $32,000 after acquiring an additional 77 shares during the last quarter. Finally, POM Investment Strategies LLC bought a new stake in shares of Procter & Gamble during the 2nd quarter worth $34,000. Institutional investors and hedge funds own 65.77% of the company’s stock.

Insiders Place Their Bets

In other Procter & Gamble news, insider Balaji Purushothaman sold 8,842 shares of the company’s stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the sale, the insider now owns 11,537 shares of the company’s stock, valued at $1,902,451.30. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other Procter & Gamble news, CEO R. Alexandra Keith sold 3,373 shares of the business’s stock in a transaction that occurred on Monday, August 5th. The stock was sold at an average price of $170.00, for a total value of $573,410.00. Following the completion of the sale, the chief executive officer now owns 21,513 shares in the company, valued at approximately $3,657,210. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Balaji Purushothaman sold 8,842 shares of the firm’s stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the sale, the insider now directly owns 11,537 shares of the company’s stock, valued at $1,902,451.30. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 383,194 shares of company stock valued at $65,140,718 over the last quarter. 0.17% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on PG. Citigroup lifted their target price on Procter & Gamble from $177.00 to $190.00 and gave the stock a “buy” rating in a research note on Wednesday, July 10th. Hsbc Global Res upgraded Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. BNP Paribas began coverage on Procter & Gamble in a research note on Monday, June 24th. They set an “outperform” rating and a $187.00 target price on the stock. Deutsche Bank Aktiengesellschaft lifted their target price on Procter & Gamble from $171.00 to $176.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Finally, Jefferies Financial Group cut Procter & Gamble from a “buy” rating to a “hold” rating and lowered their target price for the stock from $182.00 to $175.00 in a research note on Wednesday, July 24th. Nine analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $175.89.

Get Our Latest Research Report on PG

Procter & Gamble Stock Up 0.6 %

Shares of NYSE PG opened at $168.16 on Wednesday. The Procter & Gamble Company has a 12 month low of $141.60 and a 12 month high of $177.94. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.51. The firm has a market capitalization of $396.88 billion, a price-to-earnings ratio of 27.48, a PEG ratio of 3.73 and a beta of 0.41. The business has a 50-day moving average of $171.09 and a 200-day moving average of $166.58.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings data on Tuesday, July 30th. The company reported $1.40 EPS for the quarter, topping the consensus estimate of $1.37 by $0.03. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The company had revenue of $20.53 billion during the quarter, compared to analyst estimates of $20.69 billion. During the same quarter in the previous year, the firm earned $1.37 earnings per share. Procter & Gamble’s revenue was down .1% on a year-over-year basis. Sell-side analysts expect that The Procter & Gamble Company will post 6.97 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be paid a $1.0065 dividend. This represents a $4.03 annualized dividend and a yield of 2.39%. Procter & Gamble’s dividend payout ratio is currently 65.69%.

About Procter & Gamble

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Read More

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.